High-tech pen for Parkinson’s patients

Monday, March 19, 2018
Carinthian startup Tremitas designed Tremipen, a smart pen for patients with Parkinson's and Essential Tremor that enables tremor patients to measure their tremors at home and on the move. By continuously recording these values, therapies should be more individually tailored and the medication optimized. After successful application testing, World Parkinson's Day is launching a four-week crowdfunding campaign on Indiegogo on April 11, 2018, where the Tremipen will be available for pre-orders.

Daily measurements for better medical care
Tremor is the most common movement disorder in humans. In Germany, Austria, and Switzerland alone, more than 300,000 people are suffering from Parkinson's disease. In addition, younger people are becoming infected with Essential Tremor. For patients with Parkinson’s disease and Essential Tremor there is no chance of recovery. The estimate of the strength of the tremor and the resulting diagnosis with drug adjustment is usually done at the neurologist, but usually only twice a year. The Tremitas pen allows the patient to record concrete measured values themselves and continuously makes the data available to the attending physician for long-term observation. The aim is to tailor therapies individually, optimize the medication and follow up on the diagnose.

From a 'smart' pen to a comprehensive software solution
The Tremipen is a mobile sensor system in the form of a pin for precise electrical detection of the tremor. Ideally, the patient measures the strength of the tremor twice a day - preferably before and after taking the medication. The Tremipen is turned on and held loosely in the hand like a pen for 30 seconds until the measured value appears on the display. The tremor strength is given in milli-G, which describes the amplitude of the tremor. In addition, the frequency and energy of the jitter are calculated as additional parameters. The results can be tabulated and brought to the doctor's appointment. In the future, measured values will also be able to be read out through a Bluetooth interface. The calculated parameters can then be saved and visualized on a smartphone or PC app. Open interfaces of the system will enable integration into platforms for telemedicine connections. In addition, Tremitas plans an analysis and management software for medical practices and hospitals. Online services are also planned, such as a community for the exchange of experience.
The full article is available on (in German).